A new study led by researchers at the Marshall University Joan C. Edwards School of Medicine sheds light on the intricate interplay of brain regions involved in nicotine's effects on the human brain.
Feb 13, 2024
0
0
The human brain is an organ that requires 20% to 25% of the energy the body creates. This high energy demand for neuronal functions depends on the transport and precise distribution of mitochondria—the energy-generating ...
Feb 7, 2024
0
27
Women with depressive symptoms during pregnancy may experience an alteration in the circadian rhythm of cortisol—a hormone that is necessary for fetal development—which could affect the course of pregnancy. Cortisol increases ...
Feb 1, 2024
0
0
A new case report titled "Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report" has been published in Oncotarget.
Jan 24, 2024
0
0
A new editorial paper was published in Oncotarget titled, "Reductive carboxylation of glutamine as a potential target in acute myeloid leukemia."
Jan 16, 2024
0
0
The University of Oxford has launched a new clinical trial to test a vaccine to protect people against deadly Nipah virus.
Jan 11, 2024
0
0
Epithelial cells and sensory neurons communicate through neuro-epithelial connections in the GI tract, essential for major senses and digestion. Studying these interactions has been complicated due to the differing needs ...
Jan 10, 2024
0
0
In a first, Tel Aviv University researchers have discovered that the production and regulation of mitochondrial organelles in the brain's nerve cells (neurons) becomes significantly impaired with the deletion of a gene called ...
Jan 10, 2024
0
65
In-vitro-fertilization (IVF), a fertility treatment that involves fertilizing eggs in the laboratory and later implanting them in the uterus, has been a source of hope for many people struggling to conceive. However, the ...
Jan 10, 2024
0
21
A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection. ...
Jan 4, 2024
0
2
